Besifloxacin ophthalmic suspension 0.6%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Besifloxacin ophthalmic suspension 0.6%, covering 2014-09-17 to 2014-09-17. Get the full timeline:
Most recent: Clinical Trial Update: Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis [Phase 3]